Prostate Cancer - Results from #19300

Extent of extraprostatic extension independently influences biochemical recurrence-free survival: Evidence for further pT3 subclassification - Abstract January 30, 2015

Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: Analysis of urologic and primary care practices - Abstract January 30, 2015

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: A preliminary report on disease outcomes - Abstract January 30, 2015

Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy - Abstract January 30, 2015

Primary radical therapy selection in high-risk non-metastatic prostate cancer - Abstract January 30, 2015

Rectal toxicity after intensity modulated radiotherapy for prostate cancer: Which rectal dose volume constraints should we use? - Abstract January 30, 2015

Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity Scales: A survey of radiation oncologists - Abstract January 30, 2015

Rectal toxicity after proton therapy for prostate cancer: An analysis of outcomes of prospective studies conducted at the University of Florida Proton Therapy Institute - Abstract January 30, 2015

Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer - Abstract January 29, 2015

Reclassification rates are higher among African American men than Caucasians on active surveillance - Abstract January 29, 2015

Appraising the European randomized study of screening for prostate cancer: What do the results mean? - Abstract January 29, 2015

Racial disparities in oncologic outcomes after radical prostatectomy: Long-term follow-up - Abstract January 29, 2015

Challenges and choices in prostate cancer irradiation: From the three dimensional conformal radiotherapy to the era of intensity modulated, image-guided and adaptive radiation treatment - Abstract January 29, 2015

Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals - Abstract January 29, 2015

A review of statin use and prostate cancer - Abstract January 29, 2015

Assessment of the American Joint Committee on Cancer 7th edition staging for localised prostate cancer in Asia treated with external beam radiotherapy - Abstract January 29, 2015

Perfusion CT is a valuable diagnostic method for prostate cancer: A prospective study of 94 patients - Abstract January 29, 2015

Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: A French prospective observational study - Abstract January 29, 2015

Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer - Abstract January 29, 2015

High-risk prostate cancer treated with dose-escalated RT: An analysis of hormonal therapy use and duration, and prognostic implications of PSA Nadir ≤0.2 to select men for short-term hormonal therapy - Abstract January 29, 2015

Page 966 of 1454